From July 1, 2021 to July 13, 2021, the company has repurchased 2,963,022 shares, representing 2.36% for CAD 17.86 million. With this, the company has completed the repurchase of 8,788,711 shares, representing 6.86% for CAD 48.93 million under the buyback announced on July 10, 2020.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.72 CAD | -1.21% | +0.35% | +10.21% |
Mar. 22 | Knight Therapeutics Price Target Raised to $7 at RBC | MT |
Mar. 21 | Knight Therapeutics Reports Fourth Quarter Results | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.21% | 426M | |
+10.08% | 9.12B | |
-17.63% | 4.8B | |
+0.73% | 3.8B | |
+16.55% | 3.72B | |
+27.76% | 2.58B | |
-26.11% | 2.36B | |
-30.09% | 2.11B | |
+7.15% | 1.86B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- GUD Stock
- News Knight Therapeutics Inc.
- Tranche Update on Knight Therapeutics Inc.'s Equity Buyback Plan announced on July 10, 2020.